Bipolar disorder

Bipolar disorder (BD), previously known as manic depression, is a mental disorder characterized by periods of depression and abnormally elevated mood, lasting days to weeks, and in some cases months.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 15 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Bipolar disorder (BD), previously known as manic depression, is a mental disorder characterized by periods of depression and abnormally elevated mood, lasting days to weeks, and in some cases months. If the elevated mood is severe or associated with psychosis, it is called mania; if it does not significantly affect functioning, it is called hypomania.

During mania, an individual behaves or feels abnormally energetic, happy, or irritable, and often makes impulsive and reckless decisions. There is usually sleep disturbance during manic phases. During periods of depression, the individual may experience crying, have a negative outlook, and demonstrate poor eye contact.

People with BD are at 11.7 times greater risk of dying by suicide than the general population. Approximately 34% attempt suicide during their lifetime. Among adolescents with BD, 78% engaged in self-harm.

The mechanisms of this mood disorder are not clearly understood, although some studies suggest areas for future clinical research. Structural and functional MRI studies have shown differences in brain regions in BD, such as regions involved in perceiving risk-reward and regulating emotions.

A systematic review and meta-analysis by Murri and others found that cortisol levels are "associated with the manic phase" of BD.…

Bipolar disorder (BD), previously known as manic depression, is a mental disorder characterized by periods of depression and abnormally elevated mood, lasting days to weeks, and in some cases months. If the elevated mood is severe or associated with psychosis, it is called mania; if it does not significantly affect functioning, it is called hypomania.

During mania, an individual behaves or feels abnormally energetic, happy, or irritable, and often makes impulsive and reckless decisions. There is usually sleep disturbance during manic phases. During periods of depression, the individual may experience crying, have a negative outlook, and demonstrate poor eye contact.

People with BD are at 11.7 times greater risk of dying by suicide than the general population. Approximately 34% attempt suicide during their lifetime. Among adolescents with BD, 78% engaged in self-harm.

The mechanisms of this mood disorder are not clearly understood, although some studies suggest areas for future clinical research. Structural and functional MRI studies have shown differences in brain regions in BD, such as regions involved in perceiving risk-reward and regulating emotions.

A systematic review and meta-analysis by Murri and others found that cortisol levels are "associated with the manic phase" of BD. Likewise, various other studies support an important role for hypothalamic-pituitary-adrenal axis (HPA axis). Risk for BD is thought to be influenced by genetics, environment, and ADHD.

In one respect (heritability), genetic factors may account for up to 70–90% of the risk of developing BD. In another respect (concordance rate), identical twins both have bipolar disorder (or both do not) at a rate of ~40%, in contrast to dizygotic twins' ~5%. Environmental risks include a history of child abuse and long-term stress.

A meta-analysis and a separate critical literature review have found worse prognosis and earlier onset of BD in people with childhood maltreatment and "early emotional trauma" respectively. Likewise, traumatic bonding increases risk of BD. ADHD increases the risk of developing bipolar disorder.

More research is needed to understand the nature of this association. The condition is classified as bipolar I disorder if there has been at least one manic episode, with or without depressive episodes, and as bipolar II disorder if there has been at least one hypomanic episode (but no full manic episodes) and one major depressive episode.

It is classified as cyclothymia if there are hypomanic symptoms with periods of depression that do not meet the criteria for major depressive episodes. If these symptoms are due to drugs or medical problems, they are not diagnosed as BD.

Mood stabilizers, particularly lithium, and anticonvulsants, such as lamotrigine and valproate, as well as atypical antipsychotics are used for treatment. Atypical antipsychotics are used for acute manic episodes or when mood stabilizers are ineffective or not tolerated, with long-acting injectables available for patients who struggle to maintain a medication regimen.

There is evidence that psychotherapy improves the course of BD. Use of antidepressants in depressive episodes is controversial: they can be effective, but certain classes of antidepressants increase the risk of mania. The treatment of depressive episodes, therefore, is often difficult.

Past studies have found that electroconvulsive therapy (ECT) is effective in acute manic and depressive episodes, particularly with psychosis or catatonia; likewise, past guidelines have recommended admission to a psychiatric hospital if someone is a risk to themselves or others, or involuntary treatment if someone refuses treatment. However, the Committee on Rights of Persons with Disabilities (CRPD) of the United Nations has recommended the abolition of institutionalization and forced treatments "such as sedatives, mood stabilizers, electro-convulsive treatment, and conversion therapy".

The 6–12 month prevalence of bipolar disorder is 1%, while the lifetime prevalence is between 1 and 3%. The prevalence of pediatric bipolar disorder is 3.9%, although study estimates are higher with "broad bipolar criteria" and "older minimum age". The most frequent ages of onset are 24 or 46; the distribution of onset age is bimodal.

An earlier onset is associated with worse depression and more frequent co-diagnosis of anxiety and substance use. Around 40–60% of people with BD are employed and over 80% "may take time off work for psychiatric reasons in a five year period." Occupational therapies appear cost-effective at returning people with BD to work.

Social cognition is moderately impaired in people with BD, regardless of mood state. 16% of people with BD are high functioning. As of 2021, people with BD accounted for 183 Years Lived with Disability (YLDs) per 100,000 people in the Americas (ranking 20th out of all conditions).

Risk of death due to unnatural and natural causes is 7.3 and 1.9 times higher respectively. On average, life expectancy is 12.9 years shorter.

Mood stabilizers

Lithium and the anticonvulsants carbamazepine, lamotrigine, and valproic acid are classed as mood stabilizers due to their effect on the mood states in bipolar disorder. Lithium has the best overall evidence and is considered an effective treatment for acute manic episodes, preventing relapses, and bipolar depression.

Lithium reduces the risk of suicide, self-harm, and death in people with bipolar disorder. Lithium is preferred for long-term mood stabilization. Lithium treatment is also associated with adverse effects and it has been shown to erode kidney and thyroid function over extended periods.

Valproate has become a commonly prescribed treatment and effectively treats manic episodes. Carbamazepine is less effective in preventing relapse than lithium or valproate.

Carbamazepine effectively treats manic episodes, with some evidence it has greater benefit in rapid-cycling bipolar disorder, or those with more psychotic symptoms or more symptoms similar to that of schizoaffective disorder. Lamotrigine has some efficacy in treating depression, and this benefit is greatest in more severe depression.

Lamotrigine may have a similar effectiveness to lithium for treating bipolar disorder, however, there is evidence to suggest that lamotrigine is less effective at preventing recurrent mania episodes. Lamotrigine treatment has been shown to be safer compared to lithium treatment, with less adverse effects.

Valproate and carbamazepine are teratogenic and should be avoided as a treatment in women of childbearing age, but discontinuation of these medications during pregnancy is associated with a high risk of relapse. Lithium is also teratogenic in the first trimester, though it can be acceptable during this period after careful weighing of benefits and risks.

The effectiveness of topiramate is unknown. Mood stabilizers are used for long-term maintenance but have not demonstrated the ability to quickly treat acute bipolar depression. However, several atypical antipsychotics are FDA approved to treat bipolar depression.

Antipsychotics

Antipsychotic medications are effective for short-term treatment of bipolar manic episodes and appear to be superior to lithium and anticonvulsants for this purpose. Multiple atypical antipsychotics are FDA approved to treat bipolar depression: lurasidone, quetiapine, olanzapine-fluoxetine combination, cariprazine, and lumateperone are all FDA approved for depression in bipolar disorder.

Atypical antipsychotics such as lurasidone and clozapine are also indicated for bipolar depression refractory to treatment with mood stabilizers. Olanzapine is effective in preventing relapses, although the supporting evidence is weaker than the evidence for lithium.

A 2006 review found that haloperidol was an effective treatment for acute mania, limited data supported no difference in overall efficacy between haloperidol, olanzapine or risperidone, and that it could be less effective than aripiprazole.

Antidepressants

Antidepressant monotherapy is not recommended in the treatment of bipolar disorder and does not provide any benefit over mood stabilizers. Atypical antipsychotic medications are preferred over antidepressants to augment the effects of mood stabilizers due to the lack of efficacy of antidepressants in bipolar disorder.

The FDA has approved 5 atypical antipsychotic medications to specifically treat bipolar depression. Treatment of bipolar disorder using antidepressants may carry a risk of affective switches where a person switches from depression to manic or hypomanic phases or mixed states.

There may also be a risk of accelerating cycling between phases when antidepressants are used in bipolar disorder, known as rapid cycling. The risk of affective switches is higher in bipolar I depression; antidepressants are generally avoided in bipolar I disorder or only used with mood stabilizers when they are deemed necessary.

Whether modern antidepressants cause mania or rapid cycling in bipolar disorder is highly controversial, as is whether antidepressants provide any benefit over mood stabilizers alone. Selective serotonin reuptake inhibitors and bupropion still have a risk of rapid cycling and manic switch, but it is lower than other types of antidepressants.

Serotonin-norepinephrine reuptake inhibitors, such as venlafaxine and duloxetine, tetracyclic antidepressants such as mirtazapine, and tricyclic antidepressants have higher rates of manic switch and rapid cycling.

Other drugs

Short courses of benzodiazepines are used in addition to other medications for calming effect until mood stabilizing become effective. Electroconvulsive therapy (ECT) is an effective form of treatment for acute mood disturbances in those with bipolar disorder, especially when psychotic or catatonic features are displayed.

ECT is also recommended for use in pregnant women with bipolar disorder. A single intravenous dose of ketamine may produce a rapid but transient antidepressant effect in bipolar depression, although the evidence is of low to very low certainty, and evidence for other glutamate receptor modulators or for sustained remission and safety remains inconclusive.

Gabapentin and pregabalin are not proven to be effective for treating bipolar disorder.

Children

Treating bipolar disorder in children involves medication and psychotherapy. The literature and research on the effects of psychosocial therapy on bipolar spectrum disorders are scarce, making it difficult to determine the efficacy of various therapies. Mood stabilizers and atypical antipsychotics are commonly prescribed.

Among the former, lithium is the only compound approved by the FDA for children. Psychological treatment combines normally education on the disease, group therapy, and cognitive behavioral therapy. Long-term medication is often needed.

Cost

The United States spent approximately $202.1 billion on people diagnosed with bipolar I disorder (excluding other subtypes of bipolar disorder and undiagnosed people) in 2015. One analysis estimated that the United Kingdom spent approximately £5.2 billion on the disorder in 2007.

In addition to the economic costs, bipolar disorder is a leading cause of disability and lost productivity worldwide. People with bipolar disorder are generally more disabled, have a lower level of functioning, longer duration of illness, and increased rates of work absenteeism and decreased productivity when compared to people experiencing other mental health disorders.

The decrease in the productivity seen in those who care for people with bipolar disorder also significantly contributes to these costs.

Advocacy

There are widespread issues with social stigma, stereotypes, and prejudice against individuals with a diagnosis of bipolar disorder. In 2000, actress Carrie Fisher went public with her bipolar disorder diagnosis.

She became one of the most well-recognized advocates for people with bipolar disorder in the public eye and fiercely advocated to eliminate the stigma surrounding mental illnesses, including bipolar disorder. Stephen Fried, who has written extensively on the topic, noted that Fisher helped to draw attention to the disorder's chronicity, relapsing nature, and that bipolar disorder relapses do not indicate a lack of discipline or moral shortcomings.

Since being diagnosed at age 37, actor Stephen Fry has pushed to raise awareness of the condition, with his 2006 documentary Stephen Fry: The Secret Life of the Manic Depressive. In an effort to ease the social stigma associated with bipolar disorder, the orchestra conductor Ronald Braunstein cofounded the ME/2 Orchestra with his wife Caroline Whiddon in 2011.

Braunstein was diagnosed with bipolar disorder in 1985 and his concerts with the ME/2 Orchestra were conceived in order to create a welcoming performance environment for his musical colleagues, while also raising public awareness about mental illness.

Notable cases

Numerous authors have written about bipolar disorder and many successful people have openly discussed their experience with it. Kay Redfield Jamison, a clinical psychologist and professor of psychiatry at the Johns Hopkins University School of Medicine, profiled her own bipolar disorder in her memoir An Unquiet Mind (1995).

It is likely that Grigory Potemkin, Russian statesman and alleged husband of Catherine the Great, suffered from some kind of bipolar disorder. Several celebrities have also publicly shared that they have bipolar disorder; in addition to Carrie Fisher and Stephen Fry these include Catherine Zeta-Jones, Mariah Carey, Kanye West, Jane Pauley, Demi Lovato, Selena Gomez, and Russell Brand.

John Adams, president of the United States 1787-1801, probably suffered from bipolar II, although the condition had not been named at the time. Adams exhibited periods of intense activity, temper, and "mania" alternating with times of deep depression and withdrawal, such as a documented five-day period of severe, low-energy withdrawal while in the Netherlands.

Benjamin Franklin noted that Adams "is always an honest man, often a wise one, but sometimes and in some things, absolutely out of his senses."

Media portrayals

Several dramatic works have portrayed characters with traits suggestive of the diagnosis which have been the subject of discussion by psychiatrists and film experts alike. In Mr. Jones (1993), the titular character (Richard Gere) swings from a manic episode into a depressive phase and back again, spending time in a psychiatric hospital and displaying many of the features of the syndrome.

In The Mosquito Coast (1986), Allie Fox (Harrison Ford) displays some features including recklessness, grandiosity, increased goal-directed activity and mood lability, as well as some paranoia. Psychiatrists have suggested that Willy Loman, the main character in Arthur Miller's classic play Death of a Salesman, has bipolar disorder.

The 2009 drama 90210 featured a character, Silver, who was diagnosed with bipolar disorder. Characters Jean Slater and Stacey Slater from the BBC soap EastEnders have been diagnosed with the disorder. Stacey's storyline was developed as part of the BBC's Headroom campaign.

The Channel 4 soap Brookside had earlier featured a story about bipolar disorder when the character Jimmy Corkhill was diagnosed with the condition. 2011 Showtime's political thriller drama Homeland protagonist Carrie Mathison has bipolar disorder, which she has kept secret since her school days.

The 2014 ABC medical drama, Black Box, featured a world-renowned neuroscientist with bipolar disorder. In the TV series Dave, the eponymous main character, played by Lil Dicky as a fictionalized version of himself, is an aspiring rapper. Lil Dicky's real-life hype man GaTa also plays himself.

In one episode, after being off his medication and having an episode, GaTa tearfully confesses to having bipolar disorder. GaTa has bipolar disorder in real life but, like his character in the show, he is able to manage it with medication. Since 2024, Nicola Coughlan, has co-starred alongside Lydia West, in the British Channel 4 dark television comedy-drama Big Mood.

Coughlan portrays the leading role of Maggie who was diagnosed with bipolar disorder. In a series about two best friends navigating friendship amidst a mental health crisis.

Creativity

A link between mental illness and professional success or creativity has been suggested, including in accounts by Socrates, Seneca the Younger, and Cesare Lombroso. Despite prominence in popular culture, the link between creativity and bipolar has not been rigorously studied. This area of study also is likely affected by confirmation bias.

Some evidence suggests that some heritable component of bipolar disorder overlaps with heritable components of creativity. Probands of people with bipolar disorder are more likely to be professionally successful, as well as to demonstrate temperamental traits similar to bipolar disorder.

Furthermore, while studies of the frequency of bipolar disorder in creative population samples have been conflicting, full-blown bipolar disorder in creative samples is rare.

See also

List of people with bipolar disorder Sleep and bipolar disorder Outline of bipolar disorder Depression and Bipolar Support Alliance

Text derived from https://en.wikipedia.org/w/index.php?oldid=1376035662 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

32 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.